ES2117197T3 - Procedimiento para la extraccion y purificacion de alfa1-antitripsina (alfa1-pi) a partir de la fraccion de cohn iv-1. - Google Patents

Procedimiento para la extraccion y purificacion de alfa1-antitripsina (alfa1-pi) a partir de la fraccion de cohn iv-1.

Info

Publication number
ES2117197T3
ES2117197T3 ES94119902T ES94119902T ES2117197T3 ES 2117197 T3 ES2117197 T3 ES 2117197T3 ES 94119902 T ES94119902 T ES 94119902T ES 94119902 T ES94119902 T ES 94119902T ES 2117197 T3 ES2117197 T3 ES 2117197T3
Authority
ES
Spain
Prior art keywords
alfa1
cohn
trypsine
fraction
extraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94119902T
Other languages
English (en)
Inventor
Silvana Arrighi
Angela Bardotti
Enzo Bucci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
I S I ISTITUTO SIEROVACCINOGEN
Sclavo SpA
Original Assignee
I S I ISTITUTO SIEROVACCINOGEN
Sclavo SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by I S I ISTITUTO SIEROVACCINOGEN, Sclavo SpA filed Critical I S I ISTITUTO SIEROVACCINOGEN
Application granted granted Critical
Publication of ES2117197T3 publication Critical patent/ES2117197T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE DESCRIBE UN PROCEDIMIENTO PARA LA EXTRACCION Y SUBSIGUIENTE PURIFICACION DE ALFA1-ANTITRIPSINA (ALFA1-PL) A PARTIR DE UNA FRACCION DE COHN IV-1, CUYO PROCESO CONSISTE EN LOS PASOS SIGUIENTES: A) SOLUBILIZACION DE LA PASTA INICIAL CONSTITUIDA POR LA FRACCION DE COHN IV-1 Y UNA PRECIPITACION FRACCIONADA; B) CROMATOGRAFIA DE INTERACCION HIDROFOBA; C) INACTIVACION VIRAL; Y D) OPERACIONES FINALES.
ES94119902T 1993-12-16 1994-12-16 Procedimiento para la extraccion y purificacion de alfa1-antitripsina (alfa1-pi) a partir de la fraccion de cohn iv-1. Expired - Lifetime ES2117197T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI930260A IT1271463B (it) 1993-12-16 1993-12-16 Processo per l'estrazione e purificazione dell'alfal-antitripsina (alfal-pi)dalla frazione iv-1 di cohn.

Publications (1)

Publication Number Publication Date
ES2117197T3 true ES2117197T3 (es) 1998-08-01

Family

ID=11350681

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94119902T Expired - Lifetime ES2117197T3 (es) 1993-12-16 1994-12-16 Procedimiento para la extraccion y purificacion de alfa1-antitripsina (alfa1-pi) a partir de la fraccion de cohn iv-1.

Country Status (5)

Country Link
EP (1) EP0717049B1 (es)
AT (1) ATE164594T1 (es)
DE (1) DE69409390T2 (es)
ES (1) ES2117197T3 (es)
IT (1) IT1271463B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2318732A (en) 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
DE19932782A1 (de) 1999-07-14 2001-01-18 Biotest Pharma Gmbh Verfahren zur chromatographischen Fraktionierung von Plasma oder Serum, so erhaltene Präparate und deren Verwendung
US7777006B2 (en) 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
CN111454351A (zh) * 2019-06-17 2020-07-28 国药集团上海血液制品有限公司 一种α1-抗胰蛋白酶的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610633B1 (fr) * 1987-02-05 1992-09-18 Lille Transfusion Sanguine Procede d'obtention d'un concentre d'a 1-antitrypsine a partir de plasma humain et son utilisation a titre de medicament

Also Published As

Publication number Publication date
ATE164594T1 (de) 1998-04-15
ITFI930260A0 (it) 1993-12-16
EP0717049A1 (en) 1996-06-19
EP0717049B1 (en) 1998-04-01
ITFI930260A1 (it) 1995-06-16
DE69409390T2 (de) 1998-10-29
DE69409390D1 (de) 1998-05-07
IT1271463B (it) 1997-05-28

Similar Documents

Publication Publication Date Title
CO4950529A1 (es) Dihidropirimidinas y productos que las contienen
DK0828717T3 (da) Fremgangsmåde til fremstilling af 3-haloalkyl-1H-pyrazol
FI991477A0 (fi) Menetelmä tolterodiinin valmistamiseksi
EP0709877A4 (en) METHOD FOR PLASMA TREATMENT
ATE165345T1 (de) Sulfonsaeurederivate zur behandlung von viruserkrankungen
ES2138603T3 (es) Procedimiento para el aislamiento de los factores ix, x y ii altamente purificados a partir del complejo protrombinico o del plasma humano.
MX9302279A (es) Metodo para la produccion del factor viii presenteen el plasma, altamente purificado.
DE69009277D1 (de) Zweistufiges Crackverfahren.
ES2014546A6 (es) Procedimiento para la obtencion de fctor activador de neutrofilos.
IT8919153A0 (it) Procedimento di depurazione di componenti polimorfi di genomi complessi.
FR2697236B1 (fr) Transporteur de tranches de pate.
ES2187534T3 (es) Procedimiento para la preparacion de n-metil-3-(metil-4-piperi dinil)-14-indol-5-etanosulfonamida.
ES2099820T3 (es) Procedimiento para la preparacion de trans-piperidina-2,5-dicarboxilatos.
DE69736180D1 (de) Behandlung von manischen erkrankungen
WO1991006521A3 (en) Chlorofluorohydrocarbon purification process
ITFI930260A1 (it) Processo per l'estrazione e purificazione dell'alfal-antitripsina (alfal-pi)dalla frazione iv-1 di cohn.
FR2686898B1 (fr) Methode de production de la l-phenylalanine.
MY113294A (en) A process for the preparation of a virus inactivated fraction containing factor viii by means of chromatographic methods
NO973366L (no) Fremgangsmåte for behandling av multippel sklerose
CA2096888A1 (en) Process for the inactivation of viruses in preparations of proteins
ATE321549T1 (de) Bromierte hexahydroxybiphenylderivate
DK0536564T3 (da) Fremgangsmåde til fremstilling af streptolysin O, intakt streptolysin O fremstillet ved denne fremgangsmåde og dets anvendelse
EP0630970A3 (en) Process for the preparation of canthaxanthin.
DK0446872T3 (da) Fremgangsmåde til fremstilling af 2,3-dichlor-5-acetylpyridin
BG95867A (bg) Метод за обработване на кожи,причиняващи слабо замъгляване

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 717049

Country of ref document: ES